May 26, 2023
January 25, 2025
This week’s newsletter included:
-
Governor’s Office of Economic Opportunity Tours Northern Utah Life Sciences Companies
-
BioUtah and Utah State University Host Networking Lunch for Industry and Academia
-
MedVentures Acquires Canyon Labs
-
Pathos Acquires Known Medicine
-
Webinar on Partnering With NIH
-
Dynatronics Announces Planned Resignation of CEO John Krier; Brian Baker Appointed Successor
-
Altitude Lab Relocates to The Gateway
-
Clene Awarded Grant From National Multiple Sclerosis Society
-
Metrodora Institute Featured in Fast Company
-
Myriad Genetics Adds Folate Receptor Alpha to Precise™ Oncology Solutions Portfolio
-
Deseret News Features Op-Ed on Research’s Impact on Creating Jobs and Supporting Businesses
-
Canary Speech Accelerates AI Speech Analysis Technology With Microsoft Cloud for Healthcare Integration
-
Renalytix Selects EVERSANA® to Expand Commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients With Type 2 Diabetes
-
Workforce Services Highlight: Hiring Youth
Featured New Member: Nusano
Recent News
- bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies
- DGENTHERA AND NUSANO SIGN LETTER OF INTENT FOR ASTATINE‑211 SUPPLY
- 2025 BIO International Recap
- Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation
- Nelson Labs to Double Cleanroom Capacity to Support Growing Demand for Sterility Assurance Services
- RATIO THERAPEUTICS AND NUSANO ENTER LONG-TERM, MULTI-ISOTOPE SUPPLY AGREEMENT TO BOOST PRODUCTION OF CANCER RADIOPHARMACEUTICALS
